K110438

Substantially Equivalent

SENSILASE PAD-IQ

Applicant: Vasamed, Inc.
Product code: DPW
Advisory panel: Cardiovascular
Date received: 2011-02-15
Decision date: 2011-05-04
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Stoughton, WI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.